Knowledge Share Search

Cues dar pistas na prevenção de recaídas

Madangopal, Rajtarun, Brendan J. Tunstall, Lauren E. Komer, Sophia J. Weber, Jennifer K. Hoots, Veronica A. Lennon, Jennifer M. Bossert, David H. Epstein, Yavin Shaham, and Bruce T. Hope. "Discriminative stimuli are sufficient for incubation of cocaine craving." eLife 8 (2019): e44427.
Publication Date

Mais de 85% das pessoas que desistem de uma droga viciante começam a usá-lo novamente dentro de um ano. A recidiva pode ocorrer após a exposição a pistas que são encontradas no ambiente que desencadeiam a memória de sua experiência de tomar drogas.

Cues dar pistas en la prevención de recaídas

Madangopal, Rajtarun, Brendan J. Tunstall, Lauren E. Komer, Sophia J. Weber, Jennifer K. Hoots, Veronica A. Lennon, Jennifer M. Bossert, David H. Epstein, Yavin Shaham, and Bruce T. Hope. "Discriminative stimuli are sufficient for incubation of cocaine craving." eLife 8 (2019): e44427.
Publication Date

Más de 85% de las personas que renunciar a una droga adictiva comienzan a usar de nuevo dentro de un año. La recidiva puede ocurrir después de la exposición a señales que se encuentran en el ambiente que desencadenan la memoria de su experiencia de toma de drogas.

Cues Give Clues in Relapse Prevention

Madangopal, Rajtarun, Brendan J. Tunstall, Lauren E. Komer, Sophia J. Weber, Jennifer K. Hoots, Veronica A. Lennon, Jennifer M. Bossert, David H. Epstein, Yavin Shaham, and Bruce T. Hope. "Discriminative stimuli are sufficient for incubation of cocaine craving." eLife 8 (2019): e44427.
Publication Date

More than 85% of people who give up an addictive drug begin using it again within a year. Relapse can occur following exposure to cues that are found in the environment which trigger the memory of their drug-taking experience.

Eficacia de las inyecciones mensuales de buprenorfina para los trastornos de uso de opioides

Haight, Barbara R., Susan M. Learned, Celine M. Laffont, Paul J. Fudala, Yue Zhao, Amanda S. Garofalo, Mark K. Greenwald et al. "Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial." The Lancet (2019).
Publication Date

El trastorno del consumo de opioides es una enfermedad crónica y recurrente y una carga sanitaria global. El tratamiento para el OUD tiende a implicar una combinación de medicación e intervención conductual.

Efficacy of Monthly Buprenorphine Injections for Opioid Use Disorders

Haight, Barbara R., Susan M. Learned, Celine M. Laffont, Paul J. Fudala, Yue Zhao, Amanda S. Garofalo, Mark K. Greenwald et al. "Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial." The Lancet (2019).
Publication Date

Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention.

A Promising Alternative to Opioid Pain Medications

Ding, Huiping, Norikazu Kiguchi, Dennis Yasuda, Pankaj R Daga, Willma E Polgar, James J Lu, Paul W Czoty, Shiroh Kishioka, Nurulain T Zaveri, and Mei-Chuan Ko. "A Bifunctional Nociceptin and Mu Opioid Receptor Agonist Is Analgesic without Opioid Side Effects in Nonhuman Primates." Science Translational Medicine 10, no. 456 (2018):
Publication Date

There is a growing problem of misuse of prescription opioids, opioid addiction, and overdose.

Uma alternativa promissora para analgésicos opioides

Ding, Huiping, Norikazu Kiguchi, Dennis Yasuda, Pankaj R Daga, Willma E Polgar, James J Lu, Paul W Czoty, Shiroh Kishioka, Nurulain T Zaveri, and Mei-Chuan Ko. "A Bifunctional Nociceptin and Mu Opioid Receptor Agonist Is Analgesic without Opioid Side Effects in Nonhuman Primates." Science Translational Medicine 10, no. 456 (2018):
Publication Date

Há um crescente problema de abuso de opioides prescrição, dependência de opiáceos e overdose.

Una prometedora alternativa a los analgésicos opioides

Ding, Huiping, Norikazu Kiguchi, Dennis Yasuda, Pankaj R Daga, Willma E Polgar, James J Lu, Paul W Czoty, Shiroh Kishioka, Nurulain T Zaveri, and Mei-Chuan Ko. "A Bifunctional Nociceptin and Mu Opioid Receptor Agonist Is Analgesic without Opioid Side Effects in Nonhuman Primates." Science Translational Medicine 10, no. 456 (2018):
Publication Date

Hay un creciente problema del uso indebido de opiáceos de prescripción, adicción a los opiáceos y sobredosis.

Infografía de comorbilidad e informe

Created by
NIDA

El término "comorbilidad" describe dos o más trastornos o enfermedades que ocurren en la misma persona. Pueden ocurrir al mismo tiempo o uno tras otro. La comorbilidad también implica interacciones entre las enfermedades que pueden empeorar el curso de ambos.

Muchas personas que desarrollan trastornos del uso de sustancias (SUD) también son diagnosticadas con trastornos mentales, y viceversa.

Comorbidity Infographic and Report

Created by
NIDA

The term “comorbidity” describes two or more disorders or illnesses occurring in the same person. They can occur at the same time or one after the other. Comorbidity also implies interactions between the illnesses that can worsen the course of both. 

Many individuals who develop substance use disorders (SUD) are also diagnosed with mental disorders, and vice versa.